ASX:1AIPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Algorae Pharmaceuticals Ltd
$0.011
+$0.001 (+4.76%)
Day Range
$0.010 – $0.011
52 Week Range
$0.005 – $0.024
Volume
876.41K
Avg Volume (10D)
479.30K
Market Cap
$22.26M
Price Chart
Market Statistics
Open$0.010
Previous Close$0.011
Day High$0.011
Day Low$0.010
52 Week High$0.024
52 Week Low$0.005
Valuation
Market Cap22.26M
Shares Outstanding2.02B
Price to Book9.38
Trading Activity
Volume876.41K
Value Traded8.95K
Bid$0.010 × 5,643,735
Ask$0.011 × 1,329,850
Performance
1 Day-4.55%
5 Day-4.55%
13 Week-30.00%
52 Week110.00%
YTD-25.00%
Technical Indicators
RSI (14)39.60
50-Day SMA$0.012
200-Day SMA$0.013
Latest News
Biotechnology
Algorae Pharmaceuticals Expands AI Drug Combination Pipeline with Multi-Anchor AOS2 Program
Algorae expands AI drug-combo pipeline with AOS2: 18 anchors, 478k+ synergy predictions across cell lines; stock set for AI-driven discovery boost.
Biotechnology
Algorae Pharmaceuticals Enters Second Drug Synergy Screening Program with Peter MacCallum Cancer Centre
Algorae launches second AOS2 synergy program with Peter MacCallum Cancer Centre's VCFG; 24 drug combos across cancers; six-month preclinical data.
Biotechnology
Algorae Pharmaceuticals Partners with Cadila to Market Two New Medicines in Australia and NZ
Algorae inks Cadila deal to market two cardio/metabolic generics in Australia & NZ; Cadila develops/manufactures; AlgoraeRx handles regulatory and marketing.
Biotechnology
Algorae Pharmaceuticals Advances Commercial Pathway as AI Platform Validation and Distribution Agreements Gather Pace
Algorae Pharmaceuticals (ASX: 1AI) advances AlgoraeOS validation and signs Dr Reddy's distribution, signals near-term oncology revenue and stronger balance sheet.